National Penn Investors Trust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$6.62M Buy
47,638
+185
+0.4% +$24.7K 0.77% 41
2015
Q4
$6.62M Buy
47,453
+1,068
+2% +$147K 0.74% 40
2015
Q3
$6.49M Buy
46,385
+1,872
+4% +$281K 0.75% 39
2015
Q2
$7.31M Buy
44,513
+958
+2% +$153K 0.79% 38
2015
Q1
$6.72M Buy
+43,555
New +$6.2M 0.71% 37
2014
Q4
Sell
-43,413
Closed -$5.19M 193
2014
Q3
$5.19M Buy
43,413
+432
+1% +$49.5K 0.61% 38
2014
Q2
$4.63M Buy
42,981
+160
+0.4% +$16.5K 0.54% 42
2014
Q1
$4.26M Buy
42,821
+10,456
+32% +$946K 0.5% 45
2013
Q4
$2.99M Buy
32,365
+393
+1% +$34.9K 0.34% 68
2013
Q3
$2.67M Buy
31,972
+59
+0.2% +$5.06K 0.33% 70
2013
Q2
$2.61M Buy
+31,913
New +$2.39M 0.33% 67

Other funds holding ELV

National Penn Investors Trust's ELV Position: Q1 2016 in Review

National Penn Investors Trust increased its Elevance Health (ELV) stake by 0.39% in Q1 2016, buying an estimated $24.7K and bringing the position to 47,638 shares worth $6.62M. The position accounts for 0.77% of the portfolio, ranked #41.

National Penn Investors Trust first reported a position in ELV in Q2 2013 and has held it in 11 quarters since. The position peaked at $7.31M in Q2 2015. 771 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

  • National Penn Investors Trust held 47,638 shares of Elevance Health worth $6.62M as of Q1 2016.
  • National Penn Investors Trust bought 185 Elevance Health shares in Q1 2016, an estimated $24.7K.
  • Elevance Health made up 0.77% of National Penn Investors Trust's portfolio in Q1 2016, its #41 holding.
  • National Penn Investors Trust first reported a position in Elevance Health in Q2 2013 and has held it in 11 quarters since.
  • National Penn Investors Trust's Elevance Health position peaked at $7.31M in Q2 2015.
  • 771 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on National Penn Investors Trust's 13F filing for Q1 2016, filed 11 May 2016.